Show simple item record

dc.contributor.authorOhya, Susumu
dc.contributor.authorKito, Hiroaki
dc.contributor.authorHatano, Noriyuki
dc.contributor.authorMuraki, Katsuhiko
dc.date.accessioned2019-10-17T02:10:56Z
dc.date.available2019-10-17T02:10:56Z
dc.date.issued2016
dc.identifier.issn0163-7258en_US
dc.identifier.doi10.1016/j.pharmthera.2016.02.001en_US
dc.identifier.urihttp://hdl.handle.net/10072/388480
dc.description.abstractA number of different ion channel types are involved in cell signaling networks, and homeostatic regulatory mechanisms contribute to the control of ion channel expression. Profiling of global gene expression using microarray technology has recently provided novel insights into the molecular mechanisms underlying the homeostatic and pathological control of ion channel expression. It has demonstrated that the dysregulation of ion channel expression is associated with the pathogenesis of neural, cardiovascular, and immune diseases as well as cancers. In addition to the transcriptional, translational, and post-translational regulation of ion channels, potentially important evidence on the mechanisms controlling ion channel expression has recently been accumulated. The regulation of alternative pre-mRNA splicing is therefore a novel therapeutic strategy for the treatment of dominant-negative splicing disorders. Epigenetic modification plays a key role in various pathological conditions through the regulation of pluripotency genes. Inhibitors of pre-mRNA splicing and histone deacetyalase/methyltransferase have potential as potent therapeutic drugs for cancers and autoimmune and inflammatory diseases. Moreover, membrane-anchoring proteins, lysosomal and proteasomal degradation-related molecules, auxiliary subunits, and pharmacological agents alter the protein folding, membrane trafficking, and post-translational modifications of ion channels, and are linked to expression-defect channelopathies. In this review, we focused on recent insights into the transcriptional, spliceosomal, epigenetic, and proteasomal regulation of ion channel expression: Ca(2+) channels (TRPC/TRPV/TRPM/TRPA/Orai), K(+) channels (voltage-gated, KV/Ca(2+)-activated, KCa/two-pore domain, K2P/inward-rectifier, Kir), and Ca(2+)-activated Cl(-) channels (TMEM16A/TMEM16B). Furthermore, this review highlights expression of these ion channels in expression-defect channelopathies.en_US
dc.description.peerreviewedYesen_US
dc.languageEnglishen_US
dc.publisherElsevieren_US
dc.publisher.placeUnited States
dc.relation.ispartofpagefrom11en_US
dc.relation.ispartofpageto43en_US
dc.relation.ispartofjournalPharmacology & Therapeuticsen_US
dc.relation.ispartofvolume160en_US
dc.subject.fieldofresearchPharmacology and Pharmaceutical Sciencesen_US
dc.subject.fieldofresearchcode1115en_US
dc.subject.keywordsScience & Technologyen_US
dc.subject.keywordsLife Sciences & Biomedicineen_US
dc.subject.keywordsPharmacology & Pharmacyen_US
dc.subject.keywordsCa2+ channelen_US
dc.subject.keywordsK+ channelen_US
dc.titleRecent advances in therapeutic strategies that focus on the regulation of ion channel expressionen_US
dc.typeJournal articleen_US
dc.type.descriptionC1 - Articlesen_US
dcterms.bibliographicCitationOhya, S; Kito, H; Hatano, N; Muraki, K, Recent advances in therapeutic strategies that focus on the regulation of ion channel expression, Pharmacology & Therapeutics, 2016, 160, pp. 11-43en_US
dc.date.updated2019-10-17T01:49:06Z
gro.hasfulltextNo Full Text
gro.griffith.authorMuraki, Katsuhiko


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record